Basic information
- Standard SMILES
CC(=O)NC1C(O)OC(COS(=O)(=O)O)C(OC2OC(C(=O)O)C(OC3OC(CO)C(OC4OC(C(=O)O)C(O)C(O)C4OS(=O)(=O)O)C(OS(=O)(=O)O)C3NS(=O)(=O)O)C(O)C2OS(=O)(=O)O)C1O- InChIKey
HTTJABKRGRZYRN-UHFFFAOYSA-N- Molecular formula
- C26H42N2O37S5
- Average molar mass
- 1,134.9 g/mol
- Monoisotopic mass
- 1,134.00699528
Overview
enoxaparin fragment has been reported in Hydropuntia edulis, Sargassum myriocystum, and other organisms with data available.
Names & identifiers
- Preferred name
- 2-O-Sulfohexopyranuronosyl-(1->4)-2-deoxy-3-O-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-O-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-O-sulfohexopyranose
- IUPAC
- 6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
Names & synonyms
DTXSID808727622-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranoseRefChem:935558GlyTouCan:G90061MSDTXCID50820351G90061MSClexaneParvoparinalpha-HeparinLMWHSandoparinPabyrin
Show more names
SubeparinTriofibanFragmin AFragmin BVitrum ABEparina [DCIT]Heparin [BAN]Adomiparin [USAN]
Database identifiers
- CAS
9005-49-6- PubChem CID
- 772
- DTXSID
DTXSID80872762
Properties
Computed structural properties
- XLogP
- -10.8
- Topological polar surface area
- 652 Ų
- Hydrogen bond donors
- 15
- Hydrogen bond acceptors
- 38
- Rotatable bonds
- 21
- Heavy atoms
- 70
- Formal charge
- 0
- Complexity
- 2,410
Experimental & physicochemical properties
Solubility1.08e+01 g/L
Physical DescriptionSolid
Safety & regulation
Toxicology
Adverse Effects
As an anticoagulant, the main risk of LMWH is bleeding. Less common adverse effects include heparin-induced thrombocytopenia, osteoporosis, spontaneous fractures, hypoaldosteronism, and hypersensitivity reactions. In assessing the need for anticoagulant medication, clinicians must consider the risks posed by bleeding versus the risks of clotting.
Toxicity SummarySigns and Symptoms of Overdose
Chemistry & industry
Pharmacology
Cellular LocationsExtracellular
Metabolite PathwaysArdeparin Action Pathway
Related reactions
0 records
No reaction records under the current filter.
Linked notes
Loading…